Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa.

Lesage C, Adnot-Desanlis L, Perceau G, Bonnet M, Palot JP, Bernard P, Reguiaï Z.

Eur J Dermatol. 2012 Sep-Oct;22(5):640-4. doi: 10.1684/ejd.2012.1795.

PMID:
22759562
2.

Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.

Fardet L, Dupuy A, Kerob D, Levy A, Allez M, Begon E, Bachelez H, Morel P, Lebbé C.

J Am Acad Dermatol. 2007 Apr;56(4):624-8. Epub 2007 Jan 22.

PMID:
17240478
3.

Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.

Mekkes JR, Bos JD.

Br J Dermatol. 2008 Feb;158(2):370-4. Epub 2007 Nov 28.

PMID:
18047504
4.

Long-term efficacy of infliximab in hidradenitis suppurativa.

Paradela S, Rodríguez-Lojo R, Fernández-Torres R, Arévalo P, Fonseca E.

J Dermatolog Treat. 2012 Aug;23(4):278-83. doi: 10.3109/09546634.2012.683767. Epub 2012 Jun 5.

PMID:
22482700
5.

Infliximab for hidradenitis suppurativa.

Sullivan TP, Welsh E, Kerdel FA, Burdick AE, Kirsner RS.

Br J Dermatol. 2003 Nov;149(5):1046-9.

PMID:
14632813
6.

Infliximab for the treatment of hidradenitis suppurativa.

Fernández-Vozmediano JM, Armario-Hita JC.

Dermatology. 2007;215(1):41-4.

PMID:
17587838
7.

Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa.

Gulliver WP, Jemec GB, Baker KA.

J Eur Acad Dermatol Venereol. 2012 Jul;26(7):911-4. doi: 10.1111/j.1468-3083.2011.04123.x. Epub 2011 May 24.

PMID:
21605174
8.

Hidradenitis suppurativa responding to treatment with infliximab.

Lasocki A, Sinclair R, Foley P, Saunders H.

Australas J Dermatol. 2010 Aug;51(3):186-90. doi: 10.1111/j.1440-0960.2010.00623.x.

PMID:
20695857
9.

Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.

van Rappard DC, Leenarts MF, Meijerink-van 't Oost L, Mekkes JR.

J Dermatolog Treat. 2012 Aug;23(4):284-9. doi: 10.3109/09546634.2011.571657. Epub 2011 Jul 14.

PMID:
21756155
10.

Etanercept: effective in the management of hidradenitis suppurativa.

Cusack C, Buckley C.

Br J Dermatol. 2006 Apr;154(4):726-9.

PMID:
16536817
11.

Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers.

Delage M, Samimi M, Atlan M, Machet L, Lorette G, Maruani A.

Acta Derm Venereol. 2011 Mar;91(2):169-71. doi: 10.2340/00015555-1025.

12.

Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.

Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA.

J Am Acad Dermatol. 2010 Feb;62(2):205-17. doi: 10.1016/j.jaad.2009.06.050.

PMID:
20115947
13.

Long-term successful adalimumab therapy in severe hidradenitis suppurativa.

Blanco R, Martínez-Taboada VM, Villa I, González-Vela MC, Fernández-Llaca H, Agudo M, González-López MA.

Arch Dermatol. 2009 May;145(5):580-4. doi: 10.1001/archdermatol.2009.49.

PMID:
19451504
14.
15.

Paradoxical effect of infliximab in a patient with hidradenitis suppurativa.

Gori A, Rossari S, Bruscino N, Tripo L.

Dermatol Ther. 2012 Jul-Aug;25(4):376-8. doi: 10.1111/j.1529-8019.2012.01471.x. No abstract available.

PMID:
22950564
16.

Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.

Rosi YL, Lowe L, Kang S.

J Dermatolog Treat. 2005 Feb;16(1):58-61.

PMID:
15897171
17.

An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa.

Leslie KS, Tripathi SV, Nguyen TV, Pauli M, Rosenblum MD.

J Am Acad Dermatol. 2014 Feb;70(2):243-51. doi: 10.1016/j.jaad.2013.09.044. Epub 2013 Dec 4.

PMID:
24314876
18.

A prospective open-label clinical trial of efficacy of the every week administration of adalimumab in the treatment of hidradenitis suppurativa.

Sotiriou E, Goussi C, Lallas A, Chovarda E, Apalla Z, Lazaridou E, Ioannides D.

J Drugs Dermatol. 2012 May;11(5 Suppl):s15-20.

PMID:
22644772
19.

Biologic drugs for the treatment of hidradenitis suppurativa: an evidence-based review.

Shuja F, Chan CS, Rosen T.

Dermatol Clin. 2010 Jul;28(3):511-21, 523-4; quiz 522-3. doi: 10.1016/j.det.2010.03.012. Review.

PMID:
20510761
20.

Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions.

Van Rappard DC, Mekkes JR.

Br J Dermatol. 2012 Jul;167(1):206-8. doi: 10.1111/j.1365-2133.2012.10807.x. Epub 2012 Mar 13. No abstract available.

PMID:
22229974
Items per page

Supplemental Content

Write to the Help Desk